Online Education Detail

Association of Diabetes Care & Education Specialists

Innovating Decisions and Empowering Action in Diabetes Management (IDEA)

Gives you the tools to effectively facilitate shared decision-making and promote better self-management based on CGM data for people with type 1 and type 2 diabetes.

Member Price
Non-Member Price

  • Description
  • Disclosures
  • Accreditation
  • Pricing
  • Credits

This new course gives you the tools to effectively facilitate shared decision-making and promote better self-management based on CGM data for people with type 1 and type 2 diabetes. After completing an overview module covering topics such as CGM basics, the role of personal and professional CGM to transform practice, CGM metrics and challenges to CGM adoption, select three interactive case scenarios to complete that are most relevant to your practice. During each case, you will hear expert faculty review CGM tracings in detail, provide their observations and analysis, and share how they would coach their clients and empower them to interpret their CGM data.

Case Study Scenarios (each scenario includes 2-3 interactive, clinical cases):
  • Nocturnal Hypoglycemia
  • Daytime Hypoglycemia
  • Hypoglycemia Unaware
  • Post-Prandial Hyperglycemia
  • Hyperglycemia All the Time
  • Rollercoaster Variability
  • No Obvious Pattern
This course was developed in collaboration between AACE, ADCES, ACCP, ASEPA/AAPA, and IDC.

Learning Outcomes

  • Clinicians will be able to evaluate diabetes management based on time in range and the frequency and severity of hypoglycemia and hyperglycemia in addition to A1C.
  • Clinicians will self-report increased confidence in their ability to utilize glucose monitoring technology to help at-risk patients prevent and manage hypoglycemia.
  • Clinicians will self-report higher confidence levels in providing encouragement and support regarding glucose monitoring by patients to improve day-to-day diabetes management.
  • Clinicians will self-report a greater confidence in utilizing glucose monitoring data to improve individual patients’ diabetes management.

Learning Objectives

  • Discuss the limitations of A1C as a marker of diabetes control
  • Explain the merits of evaluating time in range and hypoglycemic and hyperglycemic excursions and as well as A1C
  • Describe how glucose monitoring devices facilitate prevention, detection, and prompt treatment of hypoglycemia
  • Discuss improved patient outcomes associated with glucose monitoring as well as technological advances that have improved the ease of use of these devices
Activity Type: Application-based

Intended Audience

This is an application-based activity designed for individual or groups of diabetes educators, including RNs, RDs, Pharmacists, Nurse Practitioners, Clinical Nurse Specialists, Physician Assistants, MDs, and other healthcare providers interested in staying up to date on current practices of care for their patients with diabetes and other related conditions.
ADCES extends a special welcome to members of the American College of Clinical Pharmacy who have been directed to this course from ACCP's website.

Successful Completion

To receive a Statement of Credit you must attend the entire session. Your Statement of Credit will be issued electronically immediately upon submission of the evaluation form. Contact in the event you choose not to complete the evaluation form.

Course Availability

Learners will have 6 months to complete the entire course once registered, or until the course accreditation period ends on 3/13/23 (whichever comes first).
It is the policy of the Association of Diabetes Care & Education Specialists to require that anyone who has an opportunity to affect continuing education activity content (e.g., authors, presenters, and program planners) with products or services from a commercial interest with which s/he has financial relationship/s with commercial entities to participants. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of the presentation.

Relevant disclosures (or lack thereof) among education activity planners and faculty are as follows:

• Jenna Brothers, PAC – No conflicts of interest
• Wendy McLaughlin, PAC – No conflicts of interest
• Guillermo Umpierrez, MD, FACP – Merck & Co., Inc., Grant Support
• George Grunberger, MD, FACP, FACE – Novo Nordisk and Medtronic, Research Contract; Novo Nordisk, Eli Lilly, BI: Speaker Honoraria
• Timothy Bailey, MD – Abbott, Ascensia, BD, Boehringer Ingelheim, Calibra Medical, Companion Medical, Dance Biopharm, Dexcom, Eli Lilly, Glysens, Kowa, Lexicon, Medtronic, Novo Nordisk, POPS!, Diabetes Care, Sanofi, Senseonics, Taidoc, Xeris: Research Support; Abbott, Capillary Ciomedical, Eli Lilly, Medtronic, Novo Nordisk, Sanofi: Consulting Honoraria; Abbott, MannKind, Medtronic, Novo Nordisk, Sanofi, Senseonic: Speaking Honoraria
• Richard Bergenstal, MD – Abbott Diabetes Care, Consulting; Abbott Diabetes Care, Ondu, Boehringer Ingelheim, United Health Group, DexCom, Hygieia, Johnson & Johnson, Medtronic, Merck & Co, Novo Nordisk, Roche, Sanofi: Grant funding with employer
• Lawrence Blonde, MD, FACE, MACE – Eli Lilly and Company, Novo Nordisk, Sanofi: Grant Research Support; Janssen Pharmaceuticals, Inc., GlaxoSmithKline, Gilead Sciences, Inc: Honorarium; Merck & Co., Inc., Novo Nordisk, Sanofi: Honorarium Speaker, Consultant; Lexicon Pharmaceuticals, Inc: Grant/Research Support; Intarcia Therapeutics, Inc., Honorarium, Consultant Merck & Co., Inc., Grant/Research Support
• Bruce Buckingham, MD, FACE – Convatec, Insulet, Medtronic: Honorarium and Research Support; Dexcom and Tandem: Research Support
• Ji Hyun Chun, MPAS, PA-C, BC-ADM – AstraZeneca, Sanofi, Merck & Co, Mannkind, Corcept: Honorarium
• Daniel Einhorn, MD, FACP, FACE – Halozyme and Novo Nordisk: Honorarium
• Ann Peters, MD, CDE – Abbott Diabetes Care: Honorarium and Advisory fee; Becton Dickinson, Boehringer Ingelheim, Eli Lilly and Company, Lexicon, Livongo, MannKind, Merck & Co., Inc., Novo Nordisk, Omada, OptumHealth, Sanofi: Advisory fee
• Archana R. Sadhu, MD, FACE – Safgen: Advisory fee; Novo Nordisk: Speaker fee


• Jodi Lavin-Tompkins MSN, RN, CDE, BC-ADM – No conflicts of interest
• Matthew McClure – No conflicts of interest
• Jenna Brothers, PAC – No conflicts of interest
• Wendy McLaughlin, PAC – No conflicts of interest
• Ji Hyun Chun, MPAS, PA-C, BC-ADM – AstraZeneca, Intarcia, Mannkind, Merck & Co., Inc, Novo Nordisk: Honorarium
• Christel Aprigliano, MS – Insulet: Honorarium
• Christina Roth – The College Diabetes Network: Salary
• Gregg Simonson, PhD – Abbott: Grant funding with employer; Merck & Co Inc: Advisory fee to employer
• Theodore Bruno, MD – Allergan: Spouse is shareholder and employee
• Shelly Enders, PharmD – Spouse (Sanofi, Midwest Manager)
• Dana Gershenoff – Medtronic Educator Advisory Board: Educator Council Advisory Group honorarium paid to HealthPartners IDC directly. Dana receives no personal honorarium from Medtronic

Commercial Support

The educational program is provided by educational grants from Abbott, AstraZeneca, Dexcom, Janssen, Mannkind, and Novo Nordisk.

Disclosure of Relevant Financial Relationships and Mechanism to Identify and Resolve Conflicts of Interest

Undertaking review of the educational activity by a content reviewer to evaluate for potential bias, balance in presentation, evidence-based content or other indicators of integrity, and absence of bias, AND monitoring the educational activity to evaluate for commercial bias in the presentation, AND reviewing participant feedback to evaluate for commercial bias in the activity.


ANCC logo              

Registered Nurses

The Association of Diabetes Care & Education Specialists is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This program provides 3.0 contact hours of continuing education credit.

The ADCES is also accredited by the California Board of Registered Nursing (CEP#10977).

CDR logo

Registered Dietitians

The Association of Diabetes Care & Education Specialists (AM001) is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 3.0 Continuing Professional Education units (CPEUs) for completion of this activities/materials. Continuing Professional Education Provider Accreditation does not constitute endorsement by CDR of a provider, program, or materials.

ACPE logo

Registered Pharmacists

The Association of Diabetes Care & Education Specialists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program provides 3.0 contact hours (.30 CEUs) of continuing education credit.

ACPE Universal Program Number: 0069-0000-20-036-H01-P

Effective Dates: 3/13/2020 - 3/13/2023 

Certified Diabetes Care and Education Specialists

To satisfy the requirements for renewal of certification for the National Certification Board of Diabetes Educators (NCBDE), continuing education activities must be diabetes related and approved by a provider on the NCBDE list of Approved Providers ( NCBDE does not approve continuing education. The Association of Diabetes Care & Education Specialists (ADCES) is on the NCBDE list of Approved Providers.

Board Certified Advanced Diabetes Management (BC-ADM)

ADCES is the administering body for the Advanced Diabetes Management credentials. Continuing education programs offered by ADCES can be used toward fulfilling BC-ADM Certification and recertification requirements.

Member price: $0.00 

Non-Member price: $0.00 


Apply: 3.00